Access Cannabinoids Policy Seminar 
MMJ Recs
MAY 1, 2024
Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.
Cannabis Law Report
JUNE 7, 2019
The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. Cannabinoids are chemical compounds found in the cannabis plant.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 8, 2019
Edited by renowned endocannabinoid researcher, Jahan Marcu, PhD, AJEM’s inaugural issue was published last month in conjunction with a medical education seminar put on by Havas at Columbia University. Fortunately, several changes in the law over the past 20 years have created opportunities to study the health properties of cannabinoids.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Cannabis Law Report
MARCH 3, 2020
The Company will hire or joint venture with other, already existing, labs to manufacture CBD, CBG, CBC, CBN, and other products in its future cannabinoid line. With 150 different cannabinoids, over 300 terpenes, and more of each being discovered almost monthly, the product range and possibilities in this area are endless.
Expert insights. Personalized for you.
105 
Let's personalize your content